Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | BMY | AMGN | GILD | REGN |
| Company | Albireo Pharma Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 44.90 | 49.00 | 270.63 | 66.58 | 906.90 |
| High | 44.90 | 49.05 | 274.86 | 67.18 | 915.70 |
| Low | 43.99 | 48.55 | 269.64 | 66.36 | 904.41 |
| Last | 44.15 | 48.86 | 273.01 | 67.08 | 906.54 |
| Change | -0.10 | -0.13 | -0.53 | +0.05 | -0.78 |
| % Change | -0.23% | -0.27% | -0.19% | +0.07% | -0.09% |
| Volume | 1,241,200 | 16,057,100 | 2,467,100 | 8,467,000 | 373,700 |
| 20-Day Average Volume | 635,260 | 11,259,110 | 2,172,705 | 6,490,535 | 441,820 |
| Previous Close | 44.25 | 48.99 | 273.54 | 67.03 | 907.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 50.37 | 271.55 | 69.07 | 926.29 |
| 20-Day Raw Stochastic | 43.90% | 18.15% | 44.22% | 14.81% | 18.66% |
| 20-Day Relative Strength | 72.09% | 41.15% | 48.18% | 33.12% | 39.46% |
| Weighted Alpha | +16.30 | -26.02 | +11.15 | -20.78 | +13.86 |
| Today's Opinion | 88% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | +2.13% since 04/17/24 | +3.39% since 04/17/24 | +0.22% since 04/17/24 | +0.59% since 04/17/24 |
| Low | 43.53 on 02/24/23 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 891.46 on 04/19/24 |
| High | 44.90 on 03/02/23 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | -5.91% since 03/22/24 | -1.14% since 03/22/24 | -7.62% since 03/22/24 | -6.28% since 03/22/24 |
| Low | 43.31 on 02/23/23 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 45.23 on 02/03/23 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | -2.75% since 01/24/24 | -10.64% since 01/24/24 | -15.65% since 01/24/24 | -4.40% since 01/24/24 |
| Low | 17.78 on 12/27/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 45.23 on 02/03/23 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | -12.94% since 10/24/23 | -1.13% since 10/24/23 | -14.17% since 10/24/23 | +12.71% since 10/24/23 |
| Low | 16.02 on 09/07/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 45.23 on 02/03/23 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 99,290,928 | 146,720,288 | 83,457,512 | 99,589,264 |
| Shares Outstanding, K | 20,701 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 40,580,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -34,030,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 9,830,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -37,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.03 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 03/07/23 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 23.95 |